Organogenesis Stock Quote ORGO - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.345

Bid

2.34

Ask

2.35

Volume

149,803

2.26 Day's Range 2.38

1.795 52 Week Range 4.705

Market Cap

300.876M

Previous Close

2.285

Open

2.29

Last Trade

2.345

Last Trade Time

10:00:30

Financial Volume

$ 349,339

VWAP

2.332

Average Volume (3m)

861,621

Shares Outstanding

131,963,176

Dividend Yield

PE Ratio

60.80

Earnings Per Share (EPS)

0.04

Revenue

433.14M

Net Profit

4.95M

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The... Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

organogenesis.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Organogenesis Holdings Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker ORGO. The last closing price for Organogenesis was $2.29. Over the last year, Organogenesis shares have traded in a share price range of $ 1.795 to $ 4.705.

Organogenesis currently has 131,963,176 shares outstanding. The market capitalization of Organogenesis is $300.88 million. Organogenesis has a price to earnings ratio (PE ratio) of 60.80.

Overall Flow

Bearish

Net Premium

-78k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.475	-16.8439716312	2.82	3.065	2.165	1663700	2.76036354	CS
4	-0.515	-18.006993007	2.86	3.065	2.165	1292800	2.82009458	CS
12	-1.105	-32.0289855072	3.45	3.86	2.165	861621	2.96883701	CS
26	0.145	6.59090909091	2.2	4.705	1.96	914268	3.01648371	CS
52	0.395	20.2564102564	1.95	4.705	1.795	933073	3.09180312	CS
156	-19.085	-89.0573961736	21.43	23.99	1.795	1014697	6.71593993	CS
260	-4.695	-66.6903409091	7.04	24.3363	1.795	714787	7.16433388	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.27 (75.22%)	37.38M
PEGYPineapple Energy Inc	$ 0.0881 (69.75%)	179.66M
NIVFNewGenIvf Group Ltd	$ 1.9267 (48.21%)	13.5M
ULHUniversal Logistics Holdings Inc	$ 48.30 (46.85%)	99.71k
FCUVFocus Universal Inc	$ 0.4096 (44.68%)	5.23M
ISUNiSun Inc	$ 0.154 (-95.53%)	4.98M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	185.27k
NUWENewellis Inc	$ 0.1621 (-43.91%)	9.52M
NWGLNature Wood Group Ltd	$ 10.31 (-38.81%)	31.82k
BACKIMAC Holdings Inc	$ 4.005 (-21.47%)	200.3k
PEGYPineapple Energy Inc	$ 0.0881 (69.75%)	179.66M
BDRXBiodexa Pharmaceuticals PLC	$ 1.27 (75.22%)	37.38M
KTRAKintara Therapeutics Inc	$ 0.1685 (6.65%)	35.76M
INTCIntel Corporation	$ 30.97 (-11.79%)	30.67M
SQQQProShares UltraPro Short QQQ	$ 11.555 (-3.71%)	28.11M